NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, which engage an estimated 12 million investors globally each year.

This week’s momentum leaders with accelerating news flow include: DeepMarkit (OTC: MKTDF) (TSX.V: MKT), NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR), ORAGIN Foods (OTC: OGGFF) (TSX.V: OG), and Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA). Wall Street Reporter’s NEXT SUPER STOCK conferences feature disruptive innovation leaders with +10X upside potential. These emerging growth companies are pursuing multi-billion dollar market opportunities, and are at a key inflection point in their growth trajectory – with multiple catalysts in-place to drive transformational growth, and shareholder value. This selective focus on ultra high-potential leaders, has already delivered eight 10X-50X wins in the past 20 months.

DeepMarkit (OTC: MKTDF) (TSX.V: MKT) CEO Ranjeet Sundher: “Monetizing Carbon Credits On Blockchain is Multi-Billion Dollar Opportunity”


DeepMarkit (OTC: MKTDF) (TSX.V: MKT) a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investors conference is monetizing the nearly trillion dollar market for carbon credits onto the blockchain, with its


Mint Carbon


platform.

The value of traded global markets for carbon dioxide (CO2) permits grew by 164% to a record $851 billion in 2021 according to analysts at Refinitiv, and is viewed by institutional investors and hedge funds as the next hot asset asset class. This market is expected to surge ten-fold during this decade as more enterprise adopts “net-zero” carbon emissions.

DeepMarkit (OTC: MKTDF) (TSX.V: MKT) is capitalizing on this megatrend by helping carbon credit holders monetize their credits via its


Mint Carbon


platform into tradeable NFTs on the Ethereum-powered, Polygon blockchain for liquid sale on the global market 24/7. MKTDF expects to onboard its first batch of 25 million credits in the coming weeks (worth about $250 million). MKTDF generates revenues by charging a 10% minting fee to carbon credit holders, and then generates recurring revenues of about 1% every time the NFTs trade. In his interview with Wall Street Reporter, MKTDF CEO Ranjeet Sundher shared that key milestones to watch in the coming weeks are new issuers joining the MintCarbon platform, and the first NFTs being minted. Sundher says that MKTDF’s first-mover advantage in the carbon credit NFT space, combined with its deep pipeline of projects create the potential for significant revenue growth and valuation upside in coming months.


Watch DeepMarkit (OTC: MKTDF) (TSX.V: MKT) Next Super Stock video:

NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) CEO Evan Gappelberg: “NexTech is On-Ramp to Metaverse & Web 3.0 for $5.5 Trillion E-Commerce Market”


NexTech AR (OTC: NEXCF), a featured presenter at Wall Street Reporter’s “Next Super Stock” investor conference series, recently shared with investors how NEXCF is emerging as a key player in the $5.5 trillion global e-commerce market transition to web 3.0 and the metaverse. NEXCF Augmented Reality solutions enable to view products in lifelike 3D, in their own living room. This AR shopping experience bridges the gap between the physical world, and what was once a flat 2D online e-commerce experience. NEXCFs AR shopping experience is a “game changer” for the 5.5 trillion global e-commerce industry (source: Statisa 2022).

Watch NEXT SUPER STOCK (OTC: NEXCF) (CSE: NTAR) Video:

NEXCF AR solutions create billions of dollars in potential profitability and cost cost-savings for e-commerce leaders by driving +93% increases in click through rate, and -40% reductions in product returns. This value creation and ROI is driving growing demand and industry adoption of NEXCF AR solutions. Nearly 2 billion of the world’s population now shops online. Most importantly, over 72% of e-commerce is now done by mobile phone – a native platform for Augmented Reality apps like NEXCF. Global blue chip brands utilizing NexTech AR, include: Ford Mach EV, Kohls, CB2, Crate & Barrel, Pier 1, and Segway.

“NexTech’s AR solutions are rapidly becoming a ‘must-have’ for e-commerce leaders to succeed in today’s hyper-competitive market, where even marginal improvements in metrics like click-though and return-rates can mean the difference of billions of dollars to a company’s bottom line…We’re at an inflection point now, where industry demand and adoption for NexTech’s AR is accelerating and going mainstream. As E-Commerce shifts to Web 3.0 and the Metaverse, the demand for AR/3D product models becomes essential. NexTech is emerging as the “on ramp” to the Metaverse and Web 3.0 for the $5.5 trillion e-commerce industry. With over 200 million product SKU’s in e-commerce worldwide – NexTech has a potential revenue pipeline worth billions of dollars in coming years.”


Watch NEXT SUPER STOCK (OTC: NEXCF) (CSE: NTAR) Video:

April 14

– NEXCF launches Nextech Metaverse Suite. This Suite of Metaverse SaaS products unifies Nextech’s entire technology stack of 3D and AR products and apps into one, end-to-end seamless and easy to use SaaS subscription based platform. Nextech views SaaS as a significant advancement of all its 3D modelling and augmented reality solutions. SaaS integration has enormous implications for scalability and the company’s future revenue growth. With this SaaS rollout, the Company is moving away from its managed solutions and moving toward monthly recurring revenue (MRR), business scalability, and low to no-touch AR for ecommerce.

April 12

– NEXCF launches Shopify “freemium” 3D model pricing, updating the Company’s


Shopify app


, initially


launched in January


, allowing merchants to create 3D/AR models for their ecommerce site. NEXCF is also planning to integrate this same Freemium pricing with more ecommerce platforms, including BigCommerce, WooCommerce, and Magento, and is targeting Q2 2022 for completion of these integrations. These integrations will collectively place Nextech’s AI-powered 3D/AR model creation solution in front of millions of merchants globally.

April 6

– NEXCF files four pivotal non-provisional utility patents with respect to its


Aritize 3D


and


ARitize CAD


products for 3D model making, further strengthening the Company’s intellectual property position. Fenwick & West represented Nextech AR in the filings. The patents filed are as follows:

THREE-DIMENSIONAL (3D) MODEL GENERATION FROM TWO- DIMENSIONAL (2D) IMAGES – Covers core AI algorithms for creating 3D models automatically from 2D photos and is the core of Threedy tech. THREE-DIMENSIONAL (3D) MODEL ASSEMBLY – Covers the virtual assembly line concept that helps scale 3D content creation from 2D photos. MATERIAL ESTIMATION FOR THREE-DIMENSIONAL (3D) MODELING – Covers the AI/ML techniques for creating 3D textures and materials automatically from 2D reference photos. THREE-DIMENSIONAL (3D) MODEL GENERATION FROM CAD DATA – Describes the technology and process we have built to convert 3D CAD files and other solid designs into optimized 3D meshes suitable for real-time visualization on the Web and AR.

NEXCF CEO Evan Gappelberg, commented: “These patents represent the future of our IP and is a huge step forward for Nextech. Since the founding of the company we have been very strategic in strengthening our intellectual property position as we look to cement ourselves as the world’s leading 3D model factory.” He continues, “We are in the market and generating revenue with most of this technology today while we are building the groundbreaking, disruptive technology of tomorrow that is critical for 3D and AR experiences for the Metaverse. These patent applications are foundational as we lay the groundwork in preparation for the mass adoption of everything 3D. We are witnessing the 4th industrial revolution happen as the global demand for 3D/AR models is growing exponentially, and 3D technology is quickly transforming from a “nice to have ” to a “must have” for brands and businesses particularly in the 5 trillion dollar ecommerce industry.”


Watch NEXT SUPER STOCK (OTC: NEXCF) (CSE: NTAR) Video:

ORAGIN Foods (OTC: OGGFF) (TSX.V: OG) CEO Matt Lurie: “Ready to Scale with Plant-Based Brands and Next Gen Organic Retailing”


ORAGIN Foods (OTC: OGGFF) a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investor conference, is capitalizing on twin megatrends in the booming plant-based foods space and specialty organic retailing. In his recent presentation, OGGFF CEO Matt Lurie shared with investors how OGGFF is positioned for explosive growth in the coming months, as it scales its “Organic Garage” specialty retail stores and expands its portfolio of CPG brands focusing on the the plant-based and organic lifestyle.


Watch ORAGIN Foods (OTC: OGGFF)


(TSX: OG)


Next Super Stock livestream video:

OGGFF’s “Organic Garage” specialty retail stores have built up a cult following among millennial shoppers in Toronto, Canada through a fun experiential retail concept and discount pricing – “Healthier Food For Less”. OGGFF currently has four stores generating over $30 million in revenue, at strong gross margins – and is now at an inflection point – ready to scale rapidly with new locations. In his interview with Wall Street Reporter, OGGFF CEO Matt Lurie discusses the possibilities for scaling the Organic Garage brand globally, whether through company owned stores, partnerships, and or franchises.

CEO Matt Lurie is especially excited about the growth potential for OGGFF’s branded CPG (Consumer Packaged Goods) business focused on the $30 billion plant-based foods and lifestyle sector. OGGFF is leveraging its retailing domain expertise into the plant-based foods space. With a strong insight and data on what sells on retail shelves and what today’s consumers want, OGGFF is developing a suite of plant-based CPG brands through acquisitions, and internal development with a significant focus on expansion in the US market.

One of OGGFF’s recently launched CPG brands “Future of Cheese” (targeting the $900 billion dairy alternatives market) is already gaining significant traction. Developed by the world’s leading cheese experts, Future of Cheese is rolling out a full line of cheese, butter and other exciting plant-based dairy products. The brand is a hit with consumers and products are selling out on shelves weekly. OGGFF is now expanding its product portfolio to 8-10 SKU’s in coming months which will help drive market penetration with international retailers, and restaurants. OGGFF expects significant revenue growth potential as it further develops a diversified suite of synergistic CPG brands through acquisitions in coming months.


Watch ORAGIN Foods (OTC: OGGFF)


(TSX: OG)


Next Super Stock livestream video:

March 23

– OGGFF appoints Matthew Merson to the Company’s Advisory Board to support growth and expansion of the Company’s Consumer Packaged Goods (“CPG”) division. Mr. Merson is an industry executive with over 30 years of leadership roles with some of the most recognized food and beverage brands including dairy giant Danone, Coca-Cola, Glaceau, sustainable water brand Boxed Water, leading coconut water brand ZICO, and most recently, plant-based poultry company Simulate, owner of the popular brand NUGGS. Under Mr. Merson’s sales leadership, Simulate has obtained listings in over 10,000 U.S. stores including Walmart, Target, Safeway and Kroger.

April 6

– OGGFF receives FDA registration, allowing the company’s Future of Cheese CPG brands, to commence production and sales plans within the U.S. market. The U.S packaged foods industry is estimated at over $1 trillion in annual sales, according to GrandView Research.

Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA)


CMO Marvin Hausman, M.D.: “Nova’s


Psilocybin-based Therapeutics Showing Vast Potential for Autism and O


ther


Neuroinflammatory Disorders”


Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investor conference is advancing psilocybin-based novel therapeutics, targeting autism spectrum disorders, an unmet medical need with multi-billion dollar market potential. NMLSF Chief Medical Officer Dr. Marvin Hausman, M.D., has a decades-long track record of success advancing new drugs through the FDA regulatory pathways, into commercialization, generating billions of dollars in revenue. Dr. Hausman, is now bringing the “same playbook” to NMLSF for its psilocybin-based therapeutics targeting Fragile X, then potential expansion to treat other neuroinflammatory disorders, including alzheimers, and parkinsons. NMLSF plans to submit a clinical trial application to Health Canada for a Phase 2A study evaluating its psilocybin microdose therapy for Fragile X Syndrome, in the coming weeks.

NMLSF is a global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders. NMLSF is the first biotech company to achieve FDA “Orphan Drug Designation” in both the United States and European Union for the use of psilocybin in the treatment of FXS. In his interview, with Wall Street Reporter, Dr. Hausman explains his strategy for advancing NMLSF’s drug pipeline through commercialization, as he has successfully accomplished with other novel drugs during his decades-long career.


Watch NEXT SUPER STOCK Nova Mentis (OTC: NMLSF) (CSE: NOVA) Video:

“The recently completed preclinical study of repeat low doses of our psilocybin drug – every other day for 2 weeks, showed clinical responses that greatly exceeded our expectations. We significantly modulated behavioural and cognitive defects, such as recognition memory, in FXS.” NMLSF plans to submit a clinical trial application to Health Canada in the coming weeks for a Phase 2A study evaluating psilocybin microdose therapy for FXS. “Autism spectrum disorder (“ASD”) and especially FXS, the largest genetic cause of ASD, continue to have unmet medical needs. Scientists at NOVA, over the past two years, have laid the groundwork for development of potential novel psilocybin-based microdose treatment of ASD,” said NMLSF Chief Medical Officer, Dr. Marvin S. Hausman, MD.

April 8

– NMLSF contracts with Toronto Institute of Pharmaceutical Technology to formulate and manufacture psilocybin microdose capsules for its upcoming Canadian Phase 2A fragile X syndrome clinical study. NMLSF has already manufactured a large supply of >98% pure psilocybin for clinical studies and commercialization following drug approval.

March 23

– NMLSF begins patient enrollment process for its North American Observational study: Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS). NMLSF’s Observational Study will study the neuroinflammatory mRNA genetic profile contained within cheek cells from ASD and FXS patients, as well as measure serotonin levels in patient saliva. The research objective is to develop a genetic neuroinflammatory and serotonin data bank that will help establish a “Diagnostic Index” – an objective set of tools that helps to differentiate subtypes of ASD, as well as FXS, and to develop more accurate methods of diagnosis and treatment. Collected data will be analyzed using customized machine learning algorithms and used to guide design of upcoming clinical trials that will test the efficacy of psilocybin-based therapeutics in ASD and FXS. Patients enrolled in this Observational Study will have a high priority position to be enrolled in planned psilocybin microdose clinical trials in Canada and the United States. NOVA is aiming to recruit at least 300 qualifying participants; 200+ ASD/FSX patients and 100+ neurotypical controls. Patient enrollment information at:


novamentis.ca/autismstudy

“Families caring for patients with autism spectrum disorder (ASD) and fragile X syndrome (FXS) deserve new scientific and therapeutic options to improve diagnosis, quality of care and treatment outcomes. The goal of our North American ASD and FXS Observational Study is to uncover novel and meaningful ways to diagnose and treat ASD and FXS, which is particularly relevant for statistical separation between the multitude of ASD subtypes, currently differentiated rather crudely, based on behavioural analysis,” says NMLSF Chief Medical Officer, Dr. Marvin S. Hausman MD.

February 16 –

NMLSF successfully completes an oral microdose psilocybin preclinical study, in the laboratory of Dr. Viviana Trezza, Rome Tre University, Rome, Italy. The results exceeded all expectations with the findings that a very low dose of the Company’s proprietary psilocybin significantly modulated behavioural and cognitive defects, such as recognition memory, in a genetic model of fragile X syndrome (FXS). “The science team led by Dr. Hausman, together with Dr. Viviana Trezza from Roma Tre University, continues to deliver promising preclinical results. The recent oral microdose data set not only confirms but exceeds our original injectable formulation results,” says Will Rascan, CEO of NOVA. “The clear positive data is critical as we prepare to submit our clinical trial application to Health Canada for a Phase 2A study evaluating psilocybin microdose therapy for fragile X syndrome.”


Watch NEXT SUPER STOCK Nova Mentis (OTC: NMLSF) (CSE: NOVA) Video:

WALL STREET REPORTER

Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts.


www.WallStreetReporter.com


. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here:


https://tinyurl.com/2x4eznd5

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter’s NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event:

CONTACT:

WALL STREET REPORTER

(212) 871-2057 ext 7

www.WallStreetReporter.com